Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends conditional marketing approval of ceritinib

March 2, 2015

EMA awards orphan drug designation to alvocidib for AML

Feb. 26, 2015

EMA grants orphan drug status to Theravectys vaccine for ATL/L

Feb. 9, 2015

Amgen and Onyx file applications to expand approval of carfilzomib in the E.U. and U.S.

Jan. 28, 2015

EMA adopts positive opinion on Ikervis eye drops

Jan. 27, 2015

EMA grants orphan drug designation to ApoCell for GVHD

Jan. 27, 2015

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Jan. 27, 2015

Cubist's tedizolid phosphate recommended for approval in E.U. for ABSSSI

Jan. 26, 2015

The Medicines Company receives CHMP recommendations for three acute care products

Jan. 26, 2015

European CHMP recommends new approval of Eylea

Jan. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...